AGHRB: Malaria Vaccine Implementation Studies in Africa

Apply for funding to undertake implementation research to understand the optimal strategies for roll-out and scale up of the malaria vaccines RTS,S and R21 to ensure that they are deployed in the most effective and equitable way for population health benefit. Research should be conducted in at least two Sub-Saharan African countries, one of which should have a high malaria burden. They will accept applications of all sizes, including large research projects and small to medium-scale applications.